Graham Mills works as a Principal at Abingworth. The firm's known portfolio counts 13 companies.
Is Graham Mills a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Principal at Abingworth, whose known portfolio counts 13 companies
- Iambic
- Glycomine
- AdvanCell
- Atsena Therapeutics
- Solve Therapeutics
- Addition Therapeutics
- Vaxcyte
- Wugen
- Pathalys Pharma
- R1 Therapeutics
- Antares Therapeutics
- Myricx Bio
- and 1 more
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biologics, Biotech, Clinical Trials and Drug Discovery fall inside that listing.
Stage-wise, the deals at Abingworth cluster around Growth, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Graham Mills is worth approaching.
Colleagues at Abingworth
Genghis Lloyd-Harris
Senior Advisor
London, United Kingdom
Diya Malhotra
Principal
London, United Kingdom
Kurt von Emster
Managing Partner
Menlo Park, United States
Tim Haines
Managing Director
London, United Kingdom
Bali Muralidhar
Global Head of Life Sciences
London, United Kingdom
Vin Miles
Executive Director
Boston, United States
Jayson Punwani
Managing Director
Menlo Park, United States
Andrew Sinclair
Managing Director
Royal Tunbridge Wells, United Kingdom
Lucille Conroy
Principal
United Kingdom
Krishna Polu
Advisor
San Francisco, United States
Ankur Shah
Vice President
New York City, United States
Glh Lloyd Harris
Partner
London, United Kingdom
Frequently asked questions
Who is Graham Mills?
Graham Mills is a venture capital investor based in London, England, United Kingdom, listed as Principal at Abingworth. The known portfolio of that firm counts 13 companies. That portfolio belongs to the firm, not to Graham Mills personally.
What does Graham Mills invest in?
Listed sectors include Healthcare; listed focus areas include Biologics, Biotech, Clinical Trials and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Graham Mills invest at?
Abingworth appears in Growth, Seed and Series A rounds across its known deals, and Graham Mills is listed there as Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Graham Mills listed at?
Graham Mills is listed as Principal at Abingworth. 12 other people in the database share a firm with Graham Mills.
How do I contact Graham Mills?
A LinkedIn page is on file for Graham Mills. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal